A Critical Appraisal of Lipid Management in the Post-Statin Era: Comparison on Guidelines, Therapeutic Targets, and Screening in a Case-Based Framework of Lipid Management

Jared Spitz, Jaideep Patel, Anandita Agarwala, Garima Sharma, Anurag Mehta, Pradeep Natarajan, Khurram Nasir, Pamela Morris, Roger S. Blumenthal, Michael D. Shapiro

Research output: Contribution to journalArticlepeer-review

3 Scopus citations

Abstract

The role of low-density lipoprotein-cholesterol in the pathogenesis of atherosclerotic cardiovascular disease (ASCVD) is well established. Lipid management remains the cornerstone of addressing ASCVD. In addition to statin therapy, there is a large and growing number of nonstatin therapies available to manage elevated cholesterol levels. This expert panel seeks to review current international recommendations regarding lipid management. In addition, complex yet commonly encountered lipid-management cases are provided. Guidance on applying guideline-based recommendations as well as newer evidence to the evaluation and management of ASCVD-risk lipid management is then provided.

Original languageEnglish (US)
Article number101823
JournalJACC: Advances
Volume4
Issue number6P2
DOIs
StatePublished - Jun 2025

Keywords

  • atherosclerotic cardiovascular disease
  • cholesterol
  • lipids
  • pharmacotherapy
  • prevention
  • statins
  • triglycerides

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Fingerprint

Dive into the research topics of 'A Critical Appraisal of Lipid Management in the Post-Statin Era: Comparison on Guidelines, Therapeutic Targets, and Screening in a Case-Based Framework of Lipid Management'. Together they form a unique fingerprint.

Cite this